متلازمة الانقطاع عن مضادات الاكتئاب (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "متلازمة الانقطاع عن مضادات الاكتئاب" in Arabic language version.

Last modified: 21:01:00, 2 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank Arabic rank

2614nih.gov

5^th place

6^th place

1710doi.org

2^nd place

4^th place

76web.archive.org

1^st place

52archive.org

6^th place

3^rd place

21issn.org

33^rd place

8^th place

21gov.uk

401^st place

462^nd place

11fda.gov

470^th place

452^nd place

11nytimes.com

7^th place

14^th place

11justia.com

673^rd place

1,409^th place

11law360.com

6,540^th place

low place

11tushnet.blogspot.com

low place

archive.org (Global: 6^th place; Arabic: 3^rd place)

Warner، CH؛ Bobo، W؛ Warner، C؛ Reid، S؛ Rachal، J (1 أغسطس 2006). "Antidepressant discontinuation syndrome". American Family Physician. ج. 74 ع. 3: 449–56. PMID:16913164.
Damsa, C.؛ Bumb, A.؛ Bianchi-Demicheli, F.؛ وآخرون (أغسطس 2004). ""Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review". J Clin Psychiatry. ج. 65 ع. 8: 1064–8. DOI:10.4088/JCP.v65n0806. PMID:15323590.

doi.org (Global: 2^nd place; Arabic: 4^th place)

Renoir T (2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved". Front Pharmacol. ج. 4: 45. DOI:10.3389/fphar.2013.00045. PMC:3627130. PMID:23596418.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Haddad، Peter M.؛ Anderson، Ian M. (أكتوبر 2007). "Recognising and managing antidepressant discontinuation symptoms". Advances in Psychiatric Treatment. ج. 13 ع. 6: 447–57. DOI:10.1192/apt.bp.105.001966.
Haddad PM، Dursun SM (2008). "Neurological complications of psychiatric drugs: clinical features and management". Hum Psychopharmacol. ج. 23 ع. Suppl 1: 15–26. DOI:10.1002/hup.918. PMID:18098217.
Haddad، Peter M. (مارس 2001). "Antidepressant discontinuation syndromes". Drug Safety. ج. 24 ع. 3: 183–97. DOI:10.2165/00002018-200124030-00003. PMID:11347722.
Tamam، L.؛ Ozpoyraz، N. (يناير–فبراير 2002). "Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Review". Advances in Therapy. ج. 19 ع. 1: 17–26. DOI:10.1007/BF02850015. PMID:12008858.
Haddad، Peter M.؛ Anderson، Ian M. (1 نوفمبر 2007). "Recognising and managing antidepressant discontinuation symptoms". Advances in Psychiatric Treatment. ج. 13 ع. 6: 447–457. DOI:10.1192/apt.bp.105.001966. ISSN:2056-4678.
Byatt N، Deligiannidis KM، Freeman MP (فبراير 2013). "Antidepressant use in pregnancy: a critical review focused on risks and controversies". Acta Psychiatr Scand. ج. 127 ع. 2: 94–114. DOI:10.1111/acps.12042. PMC:4006272. PMID:23240634.
Christmas, M.B. (2005). "'Brain shivers': from chat room to clinic". Psychiatric Bulletin. ج. 29 ع. 6: 219–21. DOI:10.1192/pb.29.6.219.
Aronson, J. (8 أكتوبر 2005). "Bottled lightning". BMJ. ج. 331 ع. 7520: 824. DOI:10.1136/bmj.331.7520.824. PMC:1246084.
Damsa, C.؛ Bumb, A.؛ Bianchi-Demicheli, F.؛ وآخرون (أغسطس 2004). ""Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review". J Clin Psychiatry. ج. 65 ع. 8: 1064–8. DOI:10.4088/JCP.v65n0806. PMID:15323590.

fda.gov (Global: 470^th place; Arabic: 452^nd place)

"Cymbalta (Duloxetine) Discontinuation Syndrome: Issues of Scope, Severity, Duration & Management" (PDF). U.S. Food and Drug Administration (FDA). 9 يونيو 2009. مؤرشف من الأصل (PDF) في 2017-05-09. اطلع عليه بتاريخ 2016-10-17.

gov.uk (Global: 401^st place; Arabic: 462^nd place)

Expert Group on the Safety of Selective Serotonin Reuptake Inhibitors (SSRIs) (ديسمبر 2004). Weller، Ian V.D. (المحرر). "Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants" (PDF). Medicines and Healthcare Products Regulatory Agency. مؤرشف من الأصل في 2014-08-21. اطلع عليه بتاريخ 2014-08-01.

issn.org (Global: 33^rd place; Arabic: 8^th place)

portal.issn.org

Haddad، Peter M.؛ Anderson، Ian M. (1 نوفمبر 2007). "Recognising and managing antidepressant discontinuation symptoms". Advances in Psychiatric Treatment. ج. 13 ع. 6: 447–457. DOI:10.1192/apt.bp.105.001966. ISSN:2056-4678.

justia.com (Global: 673^rd place; Arabic: 1,409^th place)

dockets.justia.com

Justia. Jennifer L Saavedra v. Eli Lilly and Company نسخة محفوظة 21 نوفمبر 2018 على موقع واي باك مشين

law360.com (Global: 6,540^th place; Arabic: low place)

Overley, Jeff (29 يناير 2013). "Lilly Fights Cymbalta 'Brain Zaps' Suit, Saying It Warned Docs". Law360. مؤرشف من الأصل في 2019-01-29. اطلع عليه بتاريخ 2014-08-03.

nih.gov (Global: 5^th place; Arabic: 6^th place)

pubmed.ncbi.nlm.nih.gov

Warner، CH؛ Bobo، W؛ Warner، C؛ Reid، S؛ Rachal، J (1 أغسطس 2006). "Antidepressant discontinuation syndrome". American Family Physician. ج. 74 ع. 3: 449–56. PMID:16913164.
Renoir T (2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved". Front Pharmacol. ج. 4: 45. DOI:10.3389/fphar.2013.00045. PMC:3627130. PMID:23596418.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Haddad PM، Dursun SM (2008). "Neurological complications of psychiatric drugs: clinical features and management". Hum Psychopharmacol. ج. 23 ع. Suppl 1: 15–26. DOI:10.1002/hup.918. PMID:18098217.
Haddad، Peter M. (مارس 2001). "Antidepressant discontinuation syndromes". Drug Safety. ج. 24 ع. 3: 183–97. DOI:10.2165/00002018-200124030-00003. PMID:11347722.
Tamam، L.؛ Ozpoyraz، N. (يناير–فبراير 2002). "Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Review". Advances in Therapy. ج. 19 ع. 1: 17–26. DOI:10.1007/BF02850015. PMID:12008858.
Byatt N، Deligiannidis KM، Freeman MP (فبراير 2013). "Antidepressant use in pregnancy: a critical review focused on risks and controversies". Acta Psychiatr Scand. ج. 127 ع. 2: 94–114. DOI:10.1111/acps.12042. PMC:4006272. PMID:23240634.
Schatzberg, A.F.؛ Haddad, P.؛ Kaplan, E.M.؛ Lejoyeux, M.؛ Rosenbaum, J.F.؛ Young, A.H.؛ Zajecka, J. (1997). "Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel". J Clin Psychiatry. ج. 5u ع. 7: 5–10. PMID:9219487.
Black, K.؛ Shea, C.؛ Dursun, S.؛ Kutcher, S. (2000). "Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria". J Psychiatry Neurosci. ج. 25 ع. 3: 255–61. PMC:1407715. PMID:10863885.
Damsa, C.؛ Bumb, A.؛ Bianchi-Demicheli, F.؛ وآخرون (أغسطس 2004). ""Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review". J Clin Psychiatry. ج. 65 ع. 8: 1064–8. DOI:10.4088/JCP.v65n0806. PMID:15323590.

ncbi.nlm.nih.gov

Renoir T (2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved". Front Pharmacol. ج. 4: 45. DOI:10.3389/fphar.2013.00045. PMC:3627130. PMID:23596418.{{استشهاد بدورية محكمة}}: صيانة الاستشهاد: دوي مجاني غير معلم (link)
Gartlehner G، Hansen RA، Morgan LC، وآخرون (ديسمبر 2011). "Results". Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review (Report). Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality.
Byatt N، Deligiannidis KM، Freeman MP (فبراير 2013). "Antidepressant use in pregnancy: a critical review focused on risks and controversies". Acta Psychiatr Scand. ج. 127 ع. 2: 94–114. DOI:10.1111/acps.12042. PMC:4006272. PMID:23240634.
Aronson, J. (8 أكتوبر 2005). "Bottled lightning". BMJ. ج. 331 ع. 7520: 824. DOI:10.1136/bmj.331.7520.824. PMC:1246084.
Black, K.؛ Shea, C.؛ Dursun, S.؛ Kutcher, S. (2000). "Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria". J Psychiatry Neurosci. ج. 25 ع. 3: 255–61. PMC:1407715. PMID:10863885.

nytimes.com (Global: 7^th place; Arabic: 14^th place)

Stutz، Bruce (6 مايو 2007). "Self-Nonmedication". New York Times. مؤرشف من الأصل في 2019-05-20. اطلع عليه بتاريخ 2010-05-24.

tushnet.blogspot.com (Global: low place; Arabic: low place)

Rebecca Tushnet for Rebecca Tushnet's 43(B)log December 09, 2013 Learned intermediary doctrine doesn't bar claim at pleading stage نسخة محفوظة 3 ديسمبر 2018 على موقع واي باك مشين

web.archive.org (Global: 1^st place; Arabic: 1^st place)

"Cymbalta (Duloxetine) Discontinuation Syndrome: Issues of Scope, Severity, Duration & Management" (PDF). U.S. Food and Drug Administration (FDA). 9 يونيو 2009. مؤرشف من الأصل (PDF) في 2017-05-09. اطلع عليه بتاريخ 2016-10-17.
Stutz، Bruce (6 مايو 2007). "Self-Nonmedication". New York Times. مؤرشف من الأصل في 2019-05-20. اطلع عليه بتاريخ 2010-05-24.
Expert Group on the Safety of Selective Serotonin Reuptake Inhibitors (SSRIs) (ديسمبر 2004). Weller، Ian V.D. (المحرر). "Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants" (PDF). Medicines and Healthcare Products Regulatory Agency. مؤرشف من الأصل في 2014-08-21. اطلع عليه بتاريخ 2014-08-01.
Justia. Jennifer L Saavedra v. Eli Lilly and Company نسخة محفوظة 21 نوفمبر 2018 على موقع واي باك مشين
Overley, Jeff (29 يناير 2013). "Lilly Fights Cymbalta 'Brain Zaps' Suit, Saying It Warned Docs". Law360. مؤرشف من الأصل في 2019-01-29. اطلع عليه بتاريخ 2014-08-03.
Rebecca Tushnet for Rebecca Tushnet's 43(B)log December 09, 2013 Learned intermediary doctrine doesn't bar claim at pleading stage نسخة محفوظة 3 ديسمبر 2018 على موقع واي باك مشين

متلازمة الانقطاع عن مضادات الاكتئاب (Arabic Wikipedia)

archive.org (Global: 6th place; Arabic: 3rd place)

doi.org (Global: 2nd place; Arabic: 4th place)

fda.gov (Global: 470th place; Arabic: 452nd place)

gov.uk (Global: 401st place; Arabic: 462nd place)

issn.org (Global: 33rd place; Arabic: 8th place)